Zentalis Pharmaceuticals Inc (ZNTL)
10.98
-0.78
(-6.67%)
USD |
NASDAQ |
Apr 25, 16:00
10.98
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals Free Cash Flow (Quarterly): -40.77M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -40.77M |
| September 30, 2023 | -38.76M |
| June 30, 2023 | -79.59M |
| March 31, 2023 | -49.28M |
| December 31, 2022 | -37.49M |
| September 30, 2022 | -34.86M |
| June 30, 2022 | -43.30M |
| March 31, 2022 | -50.65M |
| December 31, 2021 | -39.21M |
| September 30, 2021 | -36.15M |
| Date | Value |
|---|---|
| June 30, 2021 | -46.93M |
| March 31, 2021 | -37.90M |
| December 31, 2020 | -28.02M |
| September 30, 2020 | -20.60M |
| June 30, 2020 | -22.06M |
| March 31, 2020 | -16.90M |
| December 31, 2019 | -13.23M |
| September 30, 2019 | -10.10M |
| June 30, 2019 | -7.126M |
| March 31, 2019 | -9.047M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-79.59M
Minimum
Jun 2023
-7.126M
Maximum
Jun 2019
-34.36M
Average
-37.49M
Median
Dec 2022
Free Cash Flow (Quarterly) Benchmarks
| Revolution Medicines Inc | -122.88M |
| Day One Biopharmaceuticals Inc | -41.38M |
| Perspective Therapeutics Inc | -9.097M |
| Electromed Inc | 3.384M |
| Xtant Medical Holdings Inc | -1.278M |